With 24 h | Without 24 h | With 24 h | Without 24 h | |||||
---|---|---|---|---|---|---|---|---|
Ki | VT | |||||||
Smallest | Largest | Smallest | Largest | Smallest | Largest | Smallest | Largest | |
Bias (%) | ||||||||
89Zr-huJ591 | − 6.2 | − 16.2 | − 12.5 | − 24.9 | − 7.0 | 7.0 | − 9.3 | − 46.7 |
89Zr-trastuzumab | − 2.7 | − 10.0 | − 2.9 | − 8.1 | − 2.2 | 3.2 | − 11.2 | − 55.4 |
89Zr-pertuzumab | − 1.5 | − 5.0 | − 2.0 | − 6.4 | − 3.0 | 0.8 | − 8.4 | − 36.0 |
Variability (%) | ||||||||
89Zr-huJ591 | 9.2 | 11.1 | 9.9 | 10.9 | 16.3 | 57.4 | 43.6 | 127.6 |
89Zr-trastuzumab | 7.2 | 10.7 | 9.6 | 16.4 | 14.6 | 22.2 | 32.3 | 92.8 |
89Zr-pertuzumab | 7.4 | 10.5 | 9.1 | 13.9 | 13.2 | 20.5 | 28.3 | 71.6 |